Adlai Nortye Group Ltd. SEC filings ANL
Adlai Nortye Group Ltd. has 114 filings in SEC EDGAR's recent list, going back to Dec 21, 2022. Its latest annual report, Form 20-F, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Apr 10, 2026 | Dec 31, 2025 |
| 20-F/A | Amended annual report (foreign issuer) | May 12, 2025 | Dec 31, 2024 |
| 20-F | Annual report (foreign issuer) | Apr 30, 2025 | Dec 31, 2024 |
| 20-F/A | Amended annual report (foreign issuer) | Feb 14, 2025 | Dec 31, 2023 |
| 20-F | Annual report (foreign issuer) | Apr 19, 2024 | Dec 31, 2023 |
Showing 5 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Singapore
- Headquarters
- Singapore
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1944552
- Former names
- Adlai Nortye Ltd. (until Aug 19, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.